Developing transparent, evidence-based allocation strategies for essential medicines is especially critical in low- and middle-income countries, where affordability and equity challenges are most acute. This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 digital issues and online access to articles $119.00 per year only $9.92 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with S.
Contact S., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack